miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway
出版年份 2015 全文链接
标题
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway
作者
关键词
microRNA, miRNA, Drug resistance, <em class=EmphasisTypeItalic >miR-634</em>, Ras-MAPK pathway, Ovarian cancer, Chemotherapy, Cisplatin, RPS6KA3, RSK2
出版物
Molecular Cancer
Volume 14, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-11-17
DOI
10.1186/s12943-015-0464-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State
- (2014) Yulin Li et al. CANCER CELL
- Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
- (2014) Corine M. Beaufort et al. PLoS One
- RSK Isoforms in Cancer Cell Invasion and Metastasis
- (2013) F. J. Sulzmaier et al. CANCER RESEARCH
- Molecular Pathways: Mitogen-Activated Protein Kinase Pathway Mutations and Drug Resistance
- (2013) A. L. Pritchard et al. CLINICAL CANCER RESEARCH
- Comprehensive analysis of alterations in the miRNome in response to photodynamic treatment
- (2013) Doris Bach et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- The Impact of miRNA-Based Molecular Diagnostics and Treatment of NRF2-Stabilized Tumors
- (2013) Shinsuke Yamamoto et al. MOLECULAR CANCER RESEARCH
- High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth
- (2013) Suvi-Katri Leivonen et al. Molecular Oncology
- Suppression of DNA-damage checkpoint signaling by Rsk-mediated phosphorylation of Mre11
- (2013) C. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Changing View of High-Grade Serous Ovarian Cancer
- (2012) E. M. J. J. Berns et al. CANCER RESEARCH
- The kinase RSK2 modulates the sensitivity of ovarian cancer cells to cisplatin
- (2012) Marijn T.M. van Jaarsveld et al. EUROPEAN JOURNAL OF CANCER
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
- (2012) Libero Santarpia et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance
- (2012) H Ray-David et al. ONCOGENE
- miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
- (2012) M T M van Jaarsveld et al. ONCOGENE
- MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms
- (2012) Y-N Liu et al. ONCOGENE
- Regulation and function of the RSK family of protein kinases
- (2011) Yves Romeo et al. BIOCHEMICAL JOURNAL
- Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
- (2011) P. Ostling et al. CANCER RESEARCH
- Epithelial ovarian cancer: Focus on genetics and animal models
- (2011) Weiwei Shan et al. CELL CYCLE
- Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity
- (2011) S. K. Wyman et al. GENOME RESEARCH
- Role of Molecular Agents and Targeted Therapy in Clinical Trials for Women With Ovarian Cancer
- (2011) Jonathan A. Ledermann et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance
- (2011) W Li et al. ONCOGENE
- Deep sequencing of microRNA precursors reveals extensive 3' end modification
- (2011) M. A. Newman et al. RNA
- Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
- (2010) H Burger et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNAs in ovarian cancer biology and therapy resistance
- (2010) Marijn T.M. van Jaarsveld et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas
- (2009) Ayse Ayhan et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
- (2009) Sebastien Cagnol et al. FEBS Journal
- Glucocorticoid-regulated microRNAs and mirtrons in acute lymphoblastic leukemia
- (2009) J Rainer et al. LEUKEMIA
- βTrCP- and Rsk1/2-Mediated Degradation of BimEL Inhibits Apoptosis
- (2009) Elinor Dehan et al. MOLECULAR CELL
- Oncogene Addiction
- (2008) I. B. Weinstein et al. CANCER RESEARCH
- A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
- (2008) Ulrike Burk et al. EMBO REPORTS
- The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
- (2008) S.-M. Park et al. GENES & DEVELOPMENT
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now